weight lossMedically directed weight loss has become a necessity for many people.  One element of a phycisian-directed program is medication.  Bariatric practices that offer medication dispensing are able to bring another tool to the battle against obesity.  Northwind Pharmaceuticals helps bariatric clinics implement pharmaceutical dispensing by providing prepackaged pharmaceuticals, labeling and tracking systems as well as guidance through the process.

One mistake clinics often make is feeling that they need to count pills and package them within the clinic.  Our service takes the pill counting risk off of the physician by providing options for medications and packaging.  Some commonly dispensed medications within bariatric clinics include:

  • Phentermine
  • Phendimetrazine
  • Metformin
  • Fluoxetine

Northwind offers clinics different packaging options for these products.  For example, some clinics will dispense Phentermine in a 30 count bottle and schedule patient follow-ups on a monthly basis.  We also see clinics dispensing Phentermine in seven day increments with weekly follow ups.  Some clinics will purchase medications in bulk bottles while others prefer unit-of-use packaging.  Northwind complements our flexible packaging with software to manage the dispensing process.  We make it easy for your practice.

Clinic business models will vary and we try to be flexible to our client’s requirements.  As a wholesale pharmaceutical distributor, Northwind Pharmaceuticals provides a wide variety of medications.  As  dispensing consultants, we help you figure out how best to use them in your practice.  Call us today at 800.722.0772 to learn more about offering medication dispensing in your practice.

Schedule a free claims analysis now.

Let’s Talk now

Healthcare Storm 2025: What Will It Be?

Phillip Berry | Jan 1st, 2025
When it comes to American healthcare, we’ve become really good at highlighting its failings. Watching the flurry of lamentations, frustrations, denigrations, and prognostications, over the last few weeks, would lead any rational person to believe that nothing is working in our healthcare system. And, not only is it “not working,” many people conclude that it … more »

continue reading

New Drugs to Market – October Update

Phillip Berry | Oct 25th, 2024
The Food and Drug Administration (FDA) approved three novel drug therapies in October. One of those therapies,  Hympavzi (marstacimab-hncq), is a medication indicated for the treatment of patients with Hemophilia A and Hemophilia B. Hympavzi utilizes a new pathway to help reduce the risk of bleeding episodes in patients with Hemophilia, a disease that impacts … more »

continue reading

Letter From a Pharmacist – On Pharmacy Closures

Phillip Berry | Oct 25th, 2024
Pharmacists have a time-honored role as an integral contributor to the delivery of health care. From the earliest apothecaries to the retail stores of today, community pharmacists have provided guidance about health, wellness and medication therapy. Their expertise ranges from preventive care to the most advanced medications used in the treatment of complex disease.  Despite … more »

continue reading